GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CLRB
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Red day on Friday for Cellectar Biosciences stock after losing 0.329%
(Updated on Apr 19, 2024)

Sell candidate since Apr 09, 2024 Loss -18.77% PDF

The Cellectar Biosciences stock price fell by -0.329% on the last day (Friday, 19th Apr 2024) from $3.04 to $3.03. It has now fallen 6 days in a row. During the last trading day the stock fluctuated 4.98% from a day low at $3.01 to a day high of $3.16. The price has fallen in 8 of the last 10 days and is down by -19.41% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -832 thousand shares and in total, 807 thousand shares were bought and sold for approximately $2.44 million.

The stock has broken the very wide and falling short-term trend down. Firstly a stronger fallrate is indicated, but false breaks and "sell-off" may occur. However, a further fall is realistic and any reactions back to the breaking point ($3.21) are considered to be a "second chance" to get out. According to the fan-theory $2.24 will represent the new bottom line of the next trend, but it is far too early to say this for certain.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CLRB Signals & Forecast

There are few to no technical positive signals at the moment. The Cellectar Biosciences stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $3.30 and $3.71. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Friday, March 22, 2024, and so far it has fallen -25.19%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Support, Risk & Stop-loss for Cellectar Biosciences stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.150 between high and low, or 4.98%. For the last week, the stock has had daily average volatility of 6.94%.

Cellectar Biosciences is oversold on RSI14 (23). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (CLRB) For The Upcoming Trading Day Of Monday 22nd

For the upcoming trading day on Monday, 22nd we expect Cellectar Biosciences to open at $3.07, and during the day (based on 14 day Average True Range), to move between $2.79 and $3.27, which gives a possible trading interval of +/-$0.241 (+/-7.95%) up or down from last closing price. If Cellectar Biosciences takes out the full calculated possible swing range there will be an estimated 15.90% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $3.59, some $0.560 (18.48%) from the current price of $3.03, our system finds the risk reward not very attractive.

Is Cellectar Biosciences stock A Buy?

Cellectar Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -6.038 Strong Sell Candidate Unchanged

Predicted Opening Price for Cellectar Biosciences of Monday, April 22, 2024

Fair opening price April 22, 2024 Current price
$3.07 ( 1.21%) $3.03

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CLRB

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 3.22 6.16 %
R2 3.16 4.27 %
R1 3.12 3.10 %
Current price: 3.03
Support S1 3.01 -0.681 %
S2 2.97 -1.85 %
S3 2.92 -3.74 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 3.78 24.75 %
R2 3.64 20.13 %
R1 3.59 18.48 %
Current price 3.03
Support S1 0 .
S2 0 .
S3 0 .

FAQ

What is the symbol for Cellectar Biosciences Stock and on which exchange is it traded?
The symbol for Cellectar Biosciences is CLRB and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Cellectar Biosciences Stock?
Cellectar Biosciences holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Cellectar Biosciences Stock?
Cellectar Biosciences Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Cellectar Biosciences Stock.

What's the current price of Cellectar Biosciences Stock?
As of the end of day on the 2024-04-19, the price of an Cellectar Biosciences (CLRB) share was $3.03.

What is the 52-week high and low for Cellectar Biosciences Stock?
The 52-week high for Cellectar Biosciences Stock is $4.45 and the 52-week low is $1.33.

What is the market capitalization of Cellectar Biosciences Stock?
As of the 2024-04-19, the market capitalization of Cellectar Biosciences is 97.749M.

When is the next earnings date for Cellectar Biosciences?
The upcoming earnings date for Cellectar Biosciences is May 02, 2024.
Click to get the best stock tips daily for free!

About Cellectar Biosciences

Cellectar Biosciences Cellectar Biosciences, Inc., a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. Its lead phospholipid drug conjugate (PDC) candidate is CLR 131 (iopofosine I-131), which is in Phase 2 clinical study in patients with relapsed or refractory (r/r) Waldenstrom's macroglobulinemia and B-cell malignancies; Phase 2B clinical study in r/r multiple myeloma (MM) patients;... CLRB Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT